Company profile RENB

Renovaro Biosciences Inc
enochian biosciences (formerly dandrit biotech usa inc.) a biopharmaceutical company, focuses on the development and commercialization of novel therapies aimed to change the course of immunotherapy treatments for hiv/aids and cancer. the company’s lead candidate eno-1001 (pre-ind) is a potentially sterilizing cure for hiv/aids. eno-2001 is an hiv vaccine in preclinical stage,... and its additional compounds eno-4001 (phase three asset), eno-4002, eno-5001, and eno-3001 are in discovery stages for prevention relapse in colon cancer patients. enochian biosciences is headquartered in los angeles, california. Show More
Quarter analysis & expected interest

There is not enough data for Renovaro Biosciences - product pipeline to provide analysis

Correlation between past revenue and Renovaro Biosciences - product pipeline search interest

There is not enough data for Renovaro Biosciences - product pipeline to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Renovaro Biosciences - product pipeline to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for RENB-HV-01 to provide analysis

Correlation between past revenue and RENB-HV-01 search interest

There is not enough data for RENB-HV-01 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for RENB-HV-01 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for autologous HIV curative treatment to provide analysis

Correlation between past revenue and autologous HIV curative treatment search interest

There is not enough data for autologous HIV curative treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for autologous HIV curative treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for RENB-HV-12 to provide analysis

Correlation between past revenue and RENB-HV-12 search interest

There is not enough data for RENB-HV-12 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for RENB-HV-12 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for therapeutic HIV vaccine to provide analysis

Correlation between past revenue and therapeutic HIV vaccine search interest

There is not enough data for therapeutic HIV vaccine to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for therapeutic HIV vaccine to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for RENB-HB-01 to provide analysis

Correlation between past revenue and RENB-HB-01 search interest

There is not enough data for RENB-HB-01 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for RENB-HB-01 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for gene therapy curative treatment for HBV to provide analysis

Correlation between past revenue and gene therapy curative treatment for HBV search interest

There is not enough data for gene therapy curative treatment for HBV to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for gene therapy curative treatment for HBV to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for RENB-DC-11 to provide analysis

Correlation between past revenue and RENB-DC-11 search interest

There is not enough data for RENB-DC-11 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for RENB-DC-11 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for allogeneic dendritic cell therapeutic vaccine for pancreatic cancer to provide analysis

Correlation between past revenue and allogeneic dendritic cell therapeutic vaccine for pancreatic cancer search interest

There is not enough data for allogeneic dendritic cell therapeutic vaccine for pancreatic cancer to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for allogeneic dendritic cell therapeutic vaccine for pancreatic cancer to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for RENB-DC-12-XX to provide analysis

Correlation between past revenue and RENB-DC-12-XX search interest

There is not enough data for RENB-DC-12-XX to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for RENB-DC-12-XX to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for allogeneic dendritic cell therapeutic vaccine for other solid tumors to provide analysis

Correlation between past revenue and allogeneic dendritic cell therapeutic vaccine for other solid tumors search interest

There is not enough data for allogeneic dendritic cell therapeutic vaccine for other solid tumors to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for allogeneic dendritic cell therapeutic vaccine for other solid tumors to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for RENB-HV-21 to provide analysis

Correlation between past revenue and RENB-HV-21 search interest

There is not enough data for RENB-HV-21 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for RENB-HV-21 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for HIV treatment with allogeneic natural killer (NK) and gamma delta T-cells to provide analysis

Correlation between past revenue and HIV treatment with allogeneic natural killer (NK) and gamma delta T-cells search interest

There is not enough data for HIV treatment with allogeneic natural killer (NK) and gamma delta T-cells to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for HIV treatment with allogeneic natural killer (NK) and gamma delta T-cells to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Renovaro Biosciences headquarters in Los Angeles to provide analysis

Correlation between past revenue and Renovaro Biosciences headquarters in Los Angeles search interest

There is not enough data for Renovaro Biosciences headquarters in Los Angeles to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Renovaro Biosciences headquarters in Los Angeles to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Enochian Biosciences changed its name to Renovaro Biosciences in August 2023 to provide analysis

Correlation between past revenue and Enochian Biosciences changed its name to Renovaro Biosciences in August 2023 search interest

There is not enough data for Enochian Biosciences changed its name to Renovaro Biosciences in August 2023 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Enochian Biosciences changed its name to Renovaro Biosciences in August 2023 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for RENB
Earnings date: 2024-03-07
Company name: Renovaro Biosciences Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-10-16T15:21:09-04:00

SEC
8-K Form - Current report, items 3.01 and 9.01 - Lunai Bioworks Inc. (0001527728) (Filer)

2025-10-15T12:06:45-04:00

SEC
DEF 14A Form - Other definitive proxy statements - Lunai Bioworks Inc. (0001527728) (Filer)

2025-09-30T13:15:00Z

AccessWire
Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense

2025-09-29T15:56:12-04:00

SEC
10-K Form - Annual report [Section 13 and 15(d), not S-K Item 405] - Lunai Bioworks Inc. (0001527728) (Filer)

2025-09-26T17:16:53-04:00

SEC
SCHEDULE 13G Form - Statement of Beneficial Ownership by Certain Investors - Lunai Bioworks Inc. (0001527728) (Subject)

2025-09-25T12:30:00Z

AccessWire
Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships

2025-09-24T20:50:00Z

AccessWire
Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

2025-09-24T16:30:50-04:00

SEC
8-K Form - Current report, items 3.03, 5.03, and 9.01 - Lunai Bioworks Inc. (0001527728) (Filer)

2025-09-11T11:00:00Z

AccessWire
Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

2025-09-09T12:47:00Z

AccessWire
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

2025-09-08T12:50:00Z

AccessWire
Lunai Bioworks Strengthens European Strategy Through Restructuring

2025-09-05T17:12:33-04:00

SEC
8-K Form - Current report, items 2.06 and 8.01 - Lunai Bioworks Inc. (0001527728) (Filer)

2025-09-04T14:05:00Z

AccessWire
Lunai Bioworks Inc. Retains American Defense International

2025-08-27T13:45:00Z

AccessWire
Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics

2025-08-26T16:45:53-04:00

SEC
8-K Form - Current report, items 5.03 and 9.01 - RENOVARO INC. (0001527728) (Filer)